|
|
 | | | |
- close
- close
- close
- close
Zetes Industries (EBR:ZTS) |
StreetInsider.com
May 16
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Zoetis+%28ZTS%29+Reveise+FDA+Approval+of+APOQUEL/8345827.html for the full story.
StreetInsider.com
Apr 30
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Zoetis+%28ZTS%29+Tops+Q1+EPS+by+9c%3B+Issues+FY13+EPS+Outlook/8288017.html for the full story.
StreetInsider.com
Apr 25
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/BMO+Capital+Upgrades+Zoetis+Inc.+%28ZTS%29+to+Market+Perform/8277343.html for the full story.
Benzinga
Apr 5
Comment
In a report published Friday, BMO Capital Markets analyst Alex Arfaei reiterated an Underperform rating and $30.00 price target on Zoetis (NYSE: ZTS).
In the report, Arfaei noted, “Shares of Zoetis are weak today in part related to the 14...
Forbes
Apr 1
Comment
AT&T Incorporated (T) maintained its quarterly dividend of 45 cents per share. The dividend is payable on May 1, 2013, to stockholders of record at the close of business on April 10, 2013.
StreetInsider.com
Apr 1
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Dividends/Zoetis+%28ZTS%29+Declares+%240.065+Quarterly+Dividend%3B+0.8%25+Yield/8220201.html for the full story.
StreetInsider.com
Mar 26
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Zoetis+%28ZTS%29+Plans+First+Post-IPO+Quarterly+Report+for+April+30th+%28PFE%29/8211605.html for the full story.
Benzinga
Mar 20
Comment
Credit Suisse initiated coverage on Zoetis (NYSE: ZTS) with a Neutral rating and a $36.00 price target.
Credit Suisse analyst Catherine Arnold noted, "ZTS is well positioned in scale and mix to benefit from longer-term macro tailwinds, but the...
Benzinga
Mar 13
Comment
Piper Jaffray initiated coverage on Zoetis (NYSE: ZTS) with an Overweight rating and a $40.00 price target.
Piper Jaffray analyst Kevin K. Ellich noted, "We have a positive outlook on the animal health industry and believe further upside in ZTS...
Benzinga
Mar 12
Comment
Hilliard Lyons initiated coverage on Zoetis (NYSE: ZTS) with a Neutral rating.
Hilliard Lyons commented, "ZTS is the first major participant in the global animal health business available to those interested in investing in the sector, which...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
